Press Release Archive
Press Releases
September 2023
09.12.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference 09.11.2023 Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine 09.05.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
August 2023
08.30.2023 Vaccines Vaccines Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union 08.30.2023 Financial Finance Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences 08.24.2023 Vaccines Vaccines European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV 08.23.2023 Corporate Partnerships FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence 08.21.2023 Vaccines Vaccines U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age 08.14.2023 Prescription Medicines Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma 08.03.2023 Corporate Partnerships Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income Countries 08.01.2023 Pfizer Reports Second-Quarter 2023 Results
July 2023
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.